Medications for Meth Addiction: What Works, What’s Being Studied, and What to Ask Your Doctor

What Other Medications Are Being Studied for Meth Cravings?

Bupropion and naltrexone aren’t the only options researchers are exploring. Mirtazapine, an antidepressant, has shown some of the more consistent early results for reducing methamphetamine use.

A randomized controlled trial by Colfax et al., published in the Archives of General Psychiatry in 2011, found that mirtazapine reduced methamphetamine use among study participants compared to placebo. A follow-up study by Coffin et al. in JAMA Psychiatry (2020) found similar reductions in use, though it didn’t show a clear reduction in associated risk behaviors. Mirtazapine for methamphetamine use disorder is still considered investigational, not a standard prescription.

Other medications and approaches under study or occasional clinical use include:

• Naltrexone alone — explored for its potential to reduce the rewarding effects of stimulant use; you can read more in our breakdown of naltrexone for meth cravings.
• Buprenorphine — approved for opioid use disorder, but considered off-protocol for methamphetamine use disorder. Some researchers have studied it in specific, carefully managed circumstances, and its use for stimulant-related symptoms requires significant clinical judgment. It is not a general stimulant treatment; see does Suboxone help with meth addiction for more on why this distinction matters.
• Topiramate and other anticonvulsants — studied in smaller trials with mixed results.

Here’s a quick summary of where things currently stand:

None of these figures should be read as promises about outcomes. They reflect published research response rates in specific study populations, not guarantees for any individual.

Why Behavioral Therapy Remains the Foundation of Meth Addiction Treatment

With no approved medication carrying the weight, behavioral treatment does most of the work in stimulant use disorder treatment today. Two approaches have the strongest evidence base.

Contingency management rewards verified abstinence, usually through a voucher or incentive system. NIDA-supported research has consistently found this to be one of the more effective interventions specifically for stimulant use disorders, including methamphetamine.

Cognitive behavioral therapy (CBT) helps people identify triggers, build coping strategies, and change thought patterns that reinforce use. It’s often paired with contingency management for a more complete approach.

This is part of why a residential inpatient program can matter so much for meth addiction treatment. Structured daily therapy, removed from familiar triggers, gives these behavioral approaches room to actually work.

How Chapter 5 Approaches Medication in Meth Addiction Treatment

At Chapter 5, medication is never treated as a standalone fix — because right now, the research doesn’t support that approach for methamphetamine use disorder. Instead, our clinical team looks at each guest individually and considers whether a studied medication, like the bupropion-naltrexone combination, might reasonably support their broader treatment plan.

That decision is always made carefully, in partnership with the guest and grounded in current evidence, not guesswork. Medical detox, individual counseling, and therapies like contingency management and CBT form the core of care, with medication considered as one possible piece rather than the whole plan.

If you’re trying to figure out what treatment for meth addiction could look like for someone specific, our team can walk through your situation and explain what’s realistic. For more on how the full continuum of care works, from medical detox through residential treatment, see our guide to meth addiction treatment in Arizona.

What to Ask Your Doctor About Medication for Meth Addiction

You don’t need to become a researcher to have a productive conversation with a treatment provider. A few direct questions can help:

• Is medication being recommended here based on published research, and which study?
• What does “off-label” mean for this specific medication, and what are the risks?
• What side effects should I watch for?
• What does the treatment plan look like if medication isn’t included?
• How will progress be measured?

If you’re weighing options for a Prescott AZ rehab center, ask directly how their medical team approaches medication for stimulant use disorder — a program that’s honest about the limits of current research is a good sign, not a red flag.

Ask our medical team whether medication could be part of your meth treatment plan. Our admissions team is available to talk through options, and you can verify your insurance before you ever commit to anything.

Frequently Asked Questions

Is there a pill that treats meth addiction the way Suboxone treats opioid addiction?
No. There is no FDA-approved medication for methamphetamine use disorder. Suboxone (buprenorphine) is approved specifically for opioid use disorder and is not an effective treatment for meth addiction on its own.

What is the most researched medication combination for meth cravings?
Extended-release naltrexone combined with bupropion has the strongest published evidence, based on the ADAPT-2 trial published in the New England Journal of Medicine (Trivedi et al., 2021).

Does mirtazapine actually reduce methamphetamine use?
Two published studies (Colfax et al., 2011; Coffin et al., 2020) found that mirtazapine reduced methamphetamine use in study participants compared to placebo. It remains an off-label, investigational option rather than a standard prescription.

If medication isn’t approved, why would a doctor prescribe anything at all?
Doctors can prescribe medications off-label when research supports a potential benefit and they judge it appropriate for a specific person. This is common in addiction medicine and is always a clinical decision, not a guaranteed solution.

Is meth detox the same as opioid detox?
No. Opioid detox has FDA-approved medications and a well-defined medical pathway. Meth detox focuses on symptom management, safety, and psychological support, since no equivalent approved medication protocol currently exists.

What actually works for meth addiction treatment today?
Behavioral approaches, particularly contingency management and cognitive behavioral therapy, currently have the strongest evidence base. Medication may play a supporting role for some people, based on individual assessment.